Cornelia Ulm

Cornelia joined Merck as Head Regulatory Affairs Biosimilars in November 2012. She has more than 20 years experience in the pharmaceutical industry. Prior to Merck, she served as Senior Director Regulatory Affairs – Biologics at Mylan, where she was responsible for all regulatory activities related to the development of Biosimilar products. Her pathway in Biosimilar development included also positions at Apotex and Biopartners, where she build up the Regulatory Departments, supported drug development and led registration procedures for Biosimilar products. During her tenure earlier at Serono, Cornelia gained widespread regulatory knowledge in the areas of CMC, non-clinical and clinical development. Cornelia has a degree in pharmacy from J.W. Goethe University of Frankfurt, Germany.